PT - JOURNAL ARTICLE AU - Nick Vordos AU - Despoina A. Gkika AU - George Maliaris AU - Konstantinos E. Tilkeridis AU - Anastasia Antoniou AU - Dimitrios V. Bandekas AU - Athanasios Ch. Mitropoulos TI - How 3D Printing and Social Media Tackles the PPE Shortage during Covid – 19 Pandemic AID - 10.1101/2020.04.27.20081372 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.27.20081372 4099 - http://medrxiv.org/content/early/2020/06/08/2020.04.27.20081372.short 4100 - http://medrxiv.org/content/early/2020/06/08/2020.04.27.20081372.full AB - During the recent Covid-19 pandemic, additive Technology and Social Media were used to tackle the shortage of Personal Protective Equipment. A literature review and a social media listening software were employed to explore the number of the users referring to specific keywords related to 3D printing and PPE. Additionally, the QALY model was recruited to highlight the importance of the PPE usage. More than 7 billion users used the keyword covid or similar in the web while mainly Twitter and Facebook were used as a world platform for PPE designs distribution through individuals and more than 100 different 3D printable PPE designs were developed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectorsAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:In our research work literature review and social media listening software used. No risk for human or animals.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNon-digital data available